Estimates Revisions Assembly Biosciences, Inc.
Stocks
ASMB
US0453962070
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
21:00:00 01/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 35.18 USD | +4.61% |
|
-0.42% | +3.44% |
| 09-01 | UBS Initiates Assembly Biosciences at Buy With $52 Price Target | MT |
| 08-21 | Certain Common Stock of Assembly Biosciences, Inc. are subject to a Lock-Up Agreement Ending on 21-AUG-2026. | CI |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| - | |||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- ASMB Stock
- Consensus Assembly Biosciences, Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
